The Art of Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Art of Investing

PICK 51.49

+0.8%

Dec 23 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Sun Tzu	10/30/2025 2:16:49 PM
	of 10713

Moderna rises after report on potential deal talks Oct 30, 2025, 12:29 GMT-4RefinitivLess than 1 min read MRNA+15.26% Shares of drugmaker Moderna MRNA rise 11.7% to $27.56 Stat News reports, citing a person familiar with the matter, that MRNA has been in talks with at least one large drugmaker "on a deal of significant scope" The nature of the potential agreement was not clear, the report said, adding that a buyout or a large partnership was on the table Moderna declined to comment on potential deal talks The vaccine maker's shares have lost over 90% from its pandemic-era highs, battered by declining COVID revenue as well as political concerns spurred by changes to U.S. vaccine policy under Health Secretary and vaccine skeptic Robert F. Kennedy Jr "In unprecedented circumstances, we made a deliberate choice to reinvest in research and development — bringing three products to approval in 2025 alone and advancing a diverse pipeline, including an expanding oncology portfolio," Moderna spokesperson Chris Ridley said in a statement ** Including session gains, stock down ~37% YTD

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next